Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
about
Next-generation sequencing in thyroid cancerThe thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population.Circulating thyroid cancer biomarkers: Current limitations and future prospects.Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.
P2860
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@ast
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@en
type
label
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@ast
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@en
prefLabel
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@ast
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@en
P2093
P2860
P1476
Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma
@en
P2093
Aislyn P Schalck
Carrie C Lubitz
David J Panka
Hyunsuk Suh
Lori J Wirth
M Jordana Bernasconi
Ryan J Sullivan
Samuel E Donovan
Sareh Parangi
Tammy M Holm
P2860
P304
P356
10.1016/J.JMOLDX.2015.08.003
P577
2015-11-26T00:00:00Z